A cancer diagnosis is frightening and can elicit much anxiety. But thanks to the evolution of innovative cancer treatments, there are more therapeutic options, reduced side effects, and an improved life expectancy.
“Cancer care today is different from a decade ago,” says Steven Paulson, M.D., president and CEO of Texas Oncology. “At Texas Oncology, our evidence-based care model treats the whole patient, focusing on improving patient outcomes and experiences.”
With more than 280 sites of service and more than 530 physicians, Texas Oncology is one of the largest community-based oncology care practices in the U.S.
In particular, the practice is focused on advancing precision oncology. This rapidly evolving approach allows physicians to select treatments that are most likely to help patients based on a genetic understanding of their disease. As specific genetic mutations are discovered, new drugs are being developed and treatments designed to target these genetic changes that cause cancer.
“We have invested in a creating a precision medicine program where all our patients with advanced cancers have molecular profiles performed,” Dr. Paulson says. In a matter of minutes, every patient in Texas Oncology with a particular mutation can be identified and physicians notified if there is a new therapy or clinical trial to treat that patient.
“With the advancements in precision medicine, we are doing more than treating cancer. We can cure more patients than ever before, and the ones that are not cured live longer with a better quality of life,” says Dr. Paulson.
The practice has also taken the lead as a trailblazer in cancer research. Establishing and supporting an expansive and robust community-based clinical trial and research program, Texas Oncology has helped develop more than 100 FDA-approved cancer therapies.
For more information about leading-edge cancer treatments visit TexasOncology.com.
Texas Oncology
888.864.4226
